Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.

Michael Leisch; Lukas Weiss; N Lindlbauer; C Jungbauer; Alexander Egle; Eva Rohde; Richard Greil; Christoph Grabmer; Lisa Pleyer

doi:10.1016/j.leukres.2017.05.006

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.

Michael Leisch (Erstautor/-in), Lukas Weiss (Co-Autor/-in), N Lindlbauer, C Jungbauer, Alexander Egle (Co-Autor/-in), Eva Rohde (Co-Autor/-in), Richard Greil (Co-Autor/-in), Christoph Grabmer (Letztautor/-in), Lisa Pleyer^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsinstitut für Transfusionsmedizin
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

10 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	12-19
Fachzeitschrift	LEUKEMIA RESEARCH
Jahrgang	59
DOIs	https://doi.org/10.1016/j.leukres.2017.05.006
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.1016/j.leukres.2017.05.006

Dieses zitieren

Leisch, M., Weiss, L., Lindlbauer, N., Jungbauer, C., Egle, A., Rohde, E., Greil, R., Grabmer, C., & Pleyer, L. (2017). Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. LEUKEMIA RESEARCH , 59, 12-19. https://doi.org/10.1016/j.leukres.2017.05.006

Leisch, Michael ; Weiss, Lukas ; Lindlbauer, N et al. / Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. in: LEUKEMIA RESEARCH 2017 ; Jahrgang 59. S. 12-19.

@article{eb00c0348597443d905a81fc64a03541,

title = "Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.",

keywords = "CONVENTIONAL CARE REGIMENS, CHRONIC MYELOMONOCYTIC LEUKEMIA, INTERNATIONAL WORKING GROUP, MYELODYSPLASTIC SYNDROMES, RESPONSE CRITERIA, ERYTHROCYTE ANTIGENS, TRANSFUSION REACTION, DISEASE, ALLOANTIBODIES, PLATELETS",

author = "Michael Leisch and Lukas Weiss and N Lindlbauer and C Jungbauer and Alexander Egle and Eva Rohde and Richard Greil and Christoph Grabmer and Lisa Pleyer",

note = "Leisch, Weiss, Egle, Greil, Pleyer: 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, Salzburg, Austria; Lindlbauer, Rohde, Grabmer: Department of Blood Group Serology and Transfusion Medicine, SALK – Paracelsus Medical University, Salzburg Austria",

year = "2017",

doi = "10.1016/j.leukres.2017.05.006",

language = "English",

volume = "59",

pages = "12--19",

journal = "LEUKEMIA RESEARCH ",

issn = "0145-2126",

}

Leisch, M , Weiss, L, Lindlbauer, N, Jungbauer, C , Egle, A , Rohde, E , Greil, R , Grabmer, C & Pleyer, L 2017, 'Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.', LEUKEMIA RESEARCH , Jg. 59, S. 12-19. https://doi.org/10.1016/j.leukres.2017.05.006

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. / Leisch, Michael (Erstautor/-in); Weiss, Lukas (Co-Autor/-in); Lindlbauer, N et al.
in: LEUKEMIA RESEARCH , Jahrgang 59, 2017, S. 12-19.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.

AU - Leisch, Michael

AU - Weiss, Lukas

AU - Lindlbauer, N

AU - Jungbauer, C

AU - Egle, Alexander

AU - Rohde, Eva

AU - Greil, Richard

AU - Grabmer, Christoph

AU - Pleyer, Lisa

N1 - Leisch, Weiss, Egle, Greil, Pleyer: 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, Salzburg, Austria; Lindlbauer, Rohde, Grabmer: Department of Blood Group Serology and Transfusion Medicine, SALK – Paracelsus Medical University, Salzburg Austria

PY - 2017

Y1 - 2017

KW - CONVENTIONAL CARE REGIMENS

KW - CHRONIC MYELOMONOCYTIC LEUKEMIA

KW - INTERNATIONAL WORKING GROUP

KW - MYELODYSPLASTIC SYNDROMES

KW - RESPONSE CRITERIA

KW - ERYTHROCYTE ANTIGENS

KW - TRANSFUSION REACTION

KW - DISEASE

KW - ALLOANTIBODIES

KW - PLATELETS

U2 - 10.1016/j.leukres.2017.05.006

DO - 10.1016/j.leukres.2017.05.006

M3 - Original Article

C2 - 28535394

SN - 0145-2126

VL - 59

SP - 12

EP - 19

JO - LEUKEMIA RESEARCH

JF - LEUKEMIA RESEARCH

ER -

Leisch M , Weiss L, Lindlbauer N, Jungbauer C , Egle A , Rohde E et al. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience. LEUKEMIA RESEARCH . 2017;59:12-19. doi: 10.1016/j.leukres.2017.05.006